GE HealthCare Technologies Inc. (NASDAQ:GEHC) Given Consensus Rating of “Moderate Buy” by Analysts

Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) have been given an average rating of “Moderate Buy” by the eighteen research firms that are presently covering the company, MarketBeat reports. Nine investment analysts have rated the stock with a hold recommendation and nine have issued a buy recommendation on the company. The average 1 year price target among analysts that have issued ratings on the stock in the last year is $80.2105.

Several equities analysts have recently issued reports on GEHC shares. Stifel Nicolaus set a $80.00 target price on GE HealthCare Technologies in a report on Wednesday, April 29th. Jefferies Financial Group reduced their target price on GE HealthCare Technologies from $105.00 to $90.00 in a report on Thursday, April 30th. Rothschild & Co Redburn reduced their target price on GE HealthCare Technologies from $110.00 to $98.00 in a report on Thursday, April 30th. HSBC reduced their target price on GE HealthCare Technologies from $100.00 to $90.00 in a report on Thursday, April 30th. Finally, Evercore set a $80.00 target price on GE HealthCare Technologies in a report on Thursday, April 30th.

Insider Buying and Selling

In other GE HealthCare Technologies news, CEO Peter J. Arduini bought 4,169 shares of GE HealthCare Technologies stock in a transaction dated Thursday, April 30th. The stock was bought at an average cost of $59.92 per share, with a total value of $249,806.48. Following the completion of the acquisition, the chief executive officer directly owned 259,424 shares in the company, valued at approximately $15,544,686.08. The trade was a 1.63% increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CFO James Saccaro bought 3,310 shares of GE HealthCare Technologies stock in a transaction dated Friday, May 1st. The stock was acquired at an average cost of $60.60 per share, with a total value of $200,586.00. Following the completion of the acquisition, the chief financial officer owned 87,471 shares of the company’s stock, valued at $5,300,742.60. This represents a 3.93% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders purchased a total of 21,847 shares of company stock valued at $1,361,355 over the last quarter. Corporate insiders own 0.36% of the company’s stock.

Hedge Funds Weigh In On GE HealthCare Technologies

Several institutional investors and hedge funds have recently bought and sold shares of GEHC. Empowered Funds LLC grew its holdings in GE HealthCare Technologies by 6.1% during the first quarter. Empowered Funds LLC now owns 28,848 shares of the company’s stock valued at $2,328,000 after purchasing an additional 1,665 shares during the period. Acadian Asset Management LLC bought a new position in GE HealthCare Technologies during the first quarter valued at $259,000. Cresset Asset Management LLC grew its holdings in GE HealthCare Technologies by 12.5% during the second quarter. Cresset Asset Management LLC now owns 7,802 shares of the company’s stock valued at $578,000 after purchasing an additional 865 shares during the period. Jump Financial LLC grew its holdings in GE HealthCare Technologies by 317.6% during the second quarter. Jump Financial LLC now owns 28,132 shares of the company’s stock valued at $2,084,000 after purchasing an additional 21,396 shares during the period. Finally, Gamco Investors INC. ET AL grew its holdings in GE HealthCare Technologies by 8.6% during the second quarter. Gamco Investors INC. ET AL now owns 4,041 shares of the company’s stock valued at $299,000 after purchasing an additional 320 shares during the period. 82.06% of the stock is owned by institutional investors.

GE HealthCare Technologies Stock Performance

Shares of GEHC opened at $61.59 on Friday. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.95 and a current ratio of 1.22. The stock has a 50 day moving average price of $65.72 and a two-hundred day moving average price of $74.68. The firm has a market capitalization of $28.02 billion, a P/E ratio of 14.73, a P/E/G ratio of 1.66 and a beta of 0.74. GE HealthCare Technologies has a 52 week low of $58.75 and a 52 week high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings data on Wednesday, April 29th. The company reported $0.99 EPS for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.08). The company had revenue of $5.13 billion for the quarter, compared to the consensus estimate of $5.04 billion. GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.The business’s revenue for the quarter was up 7.4% on a year-over-year basis. During the same period in the prior year, the firm posted $1.01 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. Equities analysts forecast that GE HealthCare Technologies will post 4.89 earnings per share for the current fiscal year.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.